Efficacy and safety of intradetrusor botulinum toxin injections for idiopathic overactive bladder syndrome in patients with an artificial urinary sphincter

被引：0
|
作者：
Geoffroy de Sallmard
Marie-Aimée Perrouin-Verbe
Benoit Peyronnet
Xavier Biardeau
Delphine Maucort-Boulch
Emmanuel Chartier-Kastler
Véronique Phé
Alexia Even
Charles Joussain
Inès Dominique
Gérard Amarenco
Xavier Gamé
Christian Saussine
Alain Ruffion
机构：
[1] HCL,Department of Urology
[2] Department of Urology,Department of Urology
[3] CHU Rennes,Department of Urology
[4] CHU Lille,Department of Urology
[5] Department of Statistics,Department of Physical Medicine and Rehabilitation
[6] APHP,Department of Urology
[7] APHP,Department of Urology
[8] CH Les Diaconesses,Department of Urology
[9] CHU Toulouse,undefined
[10] CHU Strasbourg,undefined
来源：
World Journal of Urology | 2022年 / 40卷
关键词：
Botulinum toxins; Type A; Urinary sphincter; Artificial; Urinary incontinence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：489 / 495
页数：6
相关论文
共 50 条
  • [21] The immediate effect intradetrusor injections of botulinum neurotoxin a (BoNT/A) on the symptoms of the overactive bladder syndrome
    Kalsi, V.
    Apostolidis, A.
    Gonzales, G.
    Elneil, S.
    Dasgupta, P.
    Fowler, C. J.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 245 - 245
  • [22] Repeat Intradetrusor Injections of Onabotulinum Toxin A for Refractory Idiopathic Overactive Bladder Patients: A Single-Center Experience
    Gousse, Angelo E.
    Kanagarajah, Prashanth
    Ayyathurai, Rajinikanth
    Handa, Priyanka
    Dabas, Nikita
    Gomez, Christopher S.
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2011, 17 (05): : 253 - 257
  • [23] Intradetrusor injections of botulinum toxin A to treat urinary incontinence due to bladder overactivity during idiopathic Parkinson's disease
    Atamian, A.
    Sichez, P. C.
    Michel, F.
    Bandelier, Q.
    Fall, M.
    Gaillet, S.
    Azoulay, J. P.
    Lechevallier, E.
    Karsenty, G.
    PROGRES EN UROLOGIE, 2021, 31 (07): : 430 - 438
  • [24] Clinical outcomes of intravesical injections of botulinum toxin type A in patients with refractory idiopathic overactive bladder
    Juszczak, Kajetan
    Adamczyk, Przemyslaw
    Maciukiewicz, Piotr
    Drewa, Tomasz
    PHARMACOLOGICAL REPORTS, 2018, 70 (06) : 1133 - 1138
  • [25] Efficacy and tolerance of botulinum toxin injections after sacral nerve stimulation failure for idiopathic overactive bladder
    Baron, Maximilien
    Perrouin-Verbe, Marie-Aimee
    Lacombe, Sandy
    Paret, Fanny
    Le Normand, Loic
    Cornu, Jean-Nicolas
    NEUROUROLOGY AND URODYNAMICS, 2020, 39 (03) : 1012 - 1019
  • [26] Clinical outcomes of intravesical injections of botulinum toxin type A in patients with refractory idiopathic overactive bladder
    Kajetan Juszczak
    Przemysław Adamczyk
    Piotr Maciukiewicz
    Tomasz Drewa
    Pharmacological Reports, 2018, 70 : 1133 - 1138
  • [27] Prospective study of the clinical and urodynamic results of intradetrusor botulinum toxin injections for the treatment of neurogenic overactive bladder
    Bentaleb, Y.
    Castel-Lacanal, E.
    Sallusto, F.
    De Boissezon, X.
    Malavaud, B.
    Marque, P.
    Rischmann, P.
    Game, X.
    PROGRES EN UROLOGIE, 2008, 18 (07): : 449 - 455
  • [28] Botulinum-A Toxin's efficacy in the treatment of idiopathic overactive bladder
    Moga, Marius Alexandru
    Banciu, Simona
    Dimienescu, Oana
    Bigiu, Nicusor-Florin
    Scarneciu, Ioan
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2015, 65 (01) : 76 - 80
  • [29] PREDICTORS OF URINARY RETENTION IN MALE PATIENTS RECEIVING INTRADETRUSOR BOTULINUM TOXIN INJECTIONS
    Hoffman, Daniel
    Enemchukwu, Ekene
    Nitti, Victor
    JOURNAL OF UROLOGY, 2017, 197 (04): : E749 - E749
  • [30] Botulinum toxin A for idiopathic overactive bladder in women
    Hampel, Christian
    UROLOGIE, 2024, 63 (07): : 658 - 665
12345